JMIRx med最新文献

筛选
英文 中文
Peer Review “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study” 同行评审“SARS-CoV-2谱系(变异)和新冠肺炎疫苗接种对南非新冠肺炎疫情的影响:回归研究”
JMIRx med Pub Date : 2023-07-04 DOI: 10.2196/47143
Rephaim Mpofu
{"title":"Peer Review “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”","authors":"Rephaim Mpofu","doi":"10.2196/47143","DOIUrl":"https://doi.org/10.2196/47143","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43751956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study. 南非 SARS-CoV-2 世系(变种)和 COVID-19 疫苗接种对 COVID-19 流行的影响:回归研究。
JMIRx med Pub Date : 2023-07-03 eCollection Date: 2023-01-01 DOI: 10.2196/34598
Thabo Mabuka, Natalie Naidoo, Nesisa Ncube, Thabo Yiga, Michael Ross, Kuzivakwashe Kurehwa, Mothabisi Nare Nyathi, Andrea Silaji, Tinashe Ndemera, Tlaleng Lemeke, Ridwan Taiwo, Willie Macharia, Mthokozisi Sithole
{"title":"The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study.","authors":"Thabo Mabuka, Natalie Naidoo, Nesisa Ncube, Thabo Yiga, Michael Ross, Kuzivakwashe Kurehwa, Mothabisi Nare Nyathi, Andrea Silaji, Tinashe Ndemera, Tlaleng Lemeke, Ridwan Taiwo, Willie Macharia, Mthokozisi Sithole","doi":"10.2196/34598","DOIUrl":"10.2196/34598","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Emerging SARS-CoV-2 variants have been attributed to the occurrence of secondary, tertiary, quaternary, and quinary COVID-19 epidemic waves threatening vaccine efforts owing to their immune invasiveness. Since the importation of SARS-CoV-2 in South Africa, with the first reported COVID-19 case on March 5, 2020, South Africa has observed 5 consecutive COVID-19 epidemic waves. The evolution of SARS-CoV-2 has played a major role in the resurgence of COVID-19 epidemic waves in South Africa and across the globe.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;We aimed to conduct descriptive and inferential statistical analysis on South African COVID-19 epidemiological data to investigate the impact of SARS-CoV-2 lineages and COVID-19 vaccinations in South African COVID-19 epidemiology.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The general methodology involved the collation and stratification, covariance, regression analysis, normalization, and comparative inferential statistical analysis through null hypothesis testing (paired 2-tailed &lt;i&gt;t&lt;/i&gt; tests) of South African COVID-19 epidemiological data.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The mean daily positive COVID-19 tests in South Africa's first, second, third, fourth, and fifth COVID-19 epidemic wave periods were 11.5% (SD 8.58%), 11.5% (SD 8.45%), 13.3% (SD 9.72%), 13.1% (SD 9.91%), and 14.3% (SD 8.49%), respectively. The COVID-19 transmission rate in the first and second COVID-19 epidemic waves in South Africa was similar, while the COVID-19 transmission rate was higher in the third, fourth, and fifth COVID-19 epidemic waves than in the aforementioned waves. Most COVID-19 hospitalized cases in South Africa were in the general ward (60%-79.1%). Patients with COVID-19 on oxygen were the second-largest admission status (11.2%-16.8%), followed by patients with COVID-19 in the intensive care unit (8.07%-16.7%). Most patients hospitalized owing to COVID-19 in South Africa's first, second, third, and fourth COVID-19 epidemic waves were aged between 40 and 49 years (16.8%-20.4%) and 50 and 59 years (19.8%-25.3%). Patients admitted to the hospital owing to COVID-19 in the age groups of 0 to 19 years were relatively low (1.98%-4.59%). In general, COVID-19 hospital admissions in South Africa for the age groups between 0 and 29 years increased after each consecutive COVID-19 epidemic wave, while for age groups between 30 and 79 years, hospital admissions decreased. Most COVID-19 hospitalization deaths in South Africa in the first, second, third, fourth, and fifth COVID-19 epidemic waves were in the ages of 50 to 59 years (15.8%-24.8%), 60 to 69 years (15.9%-29.5%), and 70 to 79 years (16.6%-20.7%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The relaxation of COVID-19 nonpharmaceutical intervention health policies in South Africa and the evolution of SARS-CoV-2 were associated with increased COVID-19 transmission and severity in the South African population. COVID-19 vaccination in South Africa was strongly associ","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":"4 ","pages":"e34598"},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9839303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study” 同行评审 "SARS-CoV-2 系(变种)和 COVID-19 疫苗接种对南非 COVID-19 流行病的影响:回归研究"
JMIRx med Pub Date : 2023-07-03 DOI: 10.2196/46908
JMIRx Med, FO XSL•
{"title":"Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”","authors":"JMIRx Med, FO XSL•","doi":"10.2196/46908","DOIUrl":"https://doi.org/10.2196/46908","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139363469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors’ Response to Peer Reviews of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study” 作者对 "SARS-CoV-2 系(变种)和 COVID-19 疫苗接种对南非 COVID-19 流行的影响:回归研究"
JMIRx med Pub Date : 2023-07-03 DOI: 10.2196/46944
T. Mabuka, N. Naidoo, Nesisa Ncube, T. Yiga, Michael Ross, K. Kurehwa, Mothabisi Nare Nyathi, A. Silaji, T. Ndemera, T. Lemeke, Ridwan Taiwo, Willie Macharia, Mthokozisi Sithole
{"title":"Authors’ Response to Peer Reviews of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”","authors":"T. Mabuka, N. Naidoo, Nesisa Ncube, T. Yiga, Michael Ross, K. Kurehwa, Mothabisi Nare Nyathi, A. Silaji, T. Ndemera, T. Lemeke, Ridwan Taiwo, Willie Macharia, Mthokozisi Sithole","doi":"10.2196/46944","DOIUrl":"https://doi.org/10.2196/46944","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139363660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study” 同行评审 "SARS-CoV-2 系(变种)和 COVID-19 疫苗接种对南非 COVID-19 流行病的影响:回归研究"
JMIRx med Pub Date : 2023-07-03 DOI: 10.2196/47384
{"title":"Peer Review of “The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study”","authors":"","doi":"10.2196/47384","DOIUrl":"https://doi.org/10.2196/47384","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139363487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cross-modal sensory boosting to improve high-frequency hearing loss: A pilot study (Preprint) 改善高频听力损失的跨模态感觉增强技术:试点研究(预印本)
JMIRx med Pub Date : 2023-06-14 DOI: 10.2196/49969
I. Kohler, M. V. Perrotta, Tiago Ferreira, David Eagleman
{"title":"Cross-modal sensory boosting to improve high-frequency hearing loss: A pilot study (Preprint)","authors":"I. Kohler, M. V. Perrotta, Tiago Ferreira, David Eagleman","doi":"10.2196/49969","DOIUrl":"https://doi.org/10.2196/49969","url":null,"abstract":"","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139369999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peer Review for " Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review" “新冠肺炎急性后遗症和精神病不良后果:病因和风险系统评估方案”的同行评审
JMIRx med Pub Date : 2023-03-14 DOI: 10.2196/45308
Daniel Griffin
{"title":"Peer Review for \" Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review\"","authors":"Daniel Griffin","doi":"10.2196/45308","DOIUrl":"https://doi.org/10.2196/45308","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41725593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peer Review of "Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review" “新冠肺炎急性后遗症和精神病不良后果:病因和风险系统评估方案”的同行评审
JMIRx med Pub Date : 2023-03-14 DOI: 10.2196/45304
Dacre R T Knight
{"title":"Peer Review of \"Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review\"","authors":"Dacre R T Knight","doi":"10.2196/45304","DOIUrl":"https://doi.org/10.2196/45304","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45108195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review. 新冠肺炎急性后遗症和精神病不良后果:病因和风险系统评价方案。
JMIRx med Pub Date : 2023-03-14 DOI: 10.2196/43880
Andem Effiong
{"title":"Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review.","authors":"Andem Effiong","doi":"10.2196/43880","DOIUrl":"https://doi.org/10.2196/43880","url":null,"abstract":"<p><strong>Background: </strong>The postacute sequelae of COVID-19 (PASC) is a syndrome characterized by persistent COVID-19 symptoms or the onset of new symptoms following recovery from the initial or acute phase of the illness. Such symptoms often occur 4 or more weeks after being diagnosed with COVID-19. Although a lot of work has gone into understanding the long-term mental health effects of PASC, many questions related to the etiology and risk of this condition remain.</p><p><strong>Objective: </strong>This protocol is for a systematic review assessing the association between PASC and adverse psychiatric outcomes and whether people with PASC are at greater risk of developing an adverse psychiatric outcome than those without PASC.</p><p><strong>Methods: </strong>Various medical literature databases (eg, PubMed and EMBASE) will be searched for eligible articles, using predefined search criteria. Gray literature will also be explored. Epidemiological observational studies and secondary analyses of randomized controlled trials that report a quantitative relationship between PASC and at least one adverse psychiatric outcome will be included. The Population, Exposure of interest, Comparator, and Outcome framework will be used as a standardized framework for the inclusion criteria. The Joanna Briggs Institute critical appraisal tools will be used to assess methodological quality and critically appraise the risk of bias in included studies. A random-effects meta-analysis will be conducted if possible. A formal narrative synthesis will be performed if a meta-analysis is impossible due to substantial heterogeneity across studies. The Grading of Recommendations Assessment, Development and Evaluation approach will be used to rate the cumulative certainty of the evidence for all outcomes. Ethical approval is not required. The study results will be published in a peer-reviewed journal.</p><p><strong>Results: </strong>This study documents and addresses etiology, risk factors, and long-term symptoms of COVID-19 among people with PASC. It focuses on a key priority area for new evidence syntheses on the clinical management of COVID-19 and pandemic-related conditions. It will include evidence on nonhospitalized and hospitalized patients with a history of PASC.</p><p><strong>Conclusions: </strong>Substantial heterogeneity across studies may limit the ability to perform a meta-analysis. Findings will inform disease prevention, decision-making, health care policy, and clinical research (Reviewed by the Plan P #PeerRef Community).</p><p><strong>Trial registration: </strong>PROSPERO CRD42022308737; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=308737.</p>","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":"4 ","pages":"e43880"},"PeriodicalIF":0.0,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41175347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peer Review of "Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review" 同行评议“COVID-19急性后后遗症和不良精神结局:病因学和风险系统评价方案”
JMIRx med Pub Date : 2023-03-14 DOI: 10.2196/45306
Qianlan Yin
{"title":"Peer Review of \"Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review\"","authors":"Qianlan Yin","doi":"10.2196/45306","DOIUrl":"https://doi.org/10.2196/45306","url":null,"abstract":"<jats:p />","PeriodicalId":73558,"journal":{"name":"JMIRx med","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47367380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信